InRethinking Primary CarebyAnn Valencia·Feb 18, 2025Palivizumab Prophylaxis: Essential Guidance for Protecting High-Risk Infants from RSVWhy Palivizumab Matters for RSV Prevention
InRSV Official AnnouncementbyRSV Support Team·Mar 7, 2021About our upcoming RSVC token distribution.Explanation of the changes in token distribution.A response icon2A response icon2
InRSV Official AnnouncementbyRSV Support Team·Dec 9, 2020Details about RSVC token distributionand about listing at Exchange.
InRSV Official AnnouncementbyRSV Support Team·Aug 12, 2020On the RSV Token Generation and the progress of the ProjectAbout generation of the RSV Coin.
InRSV Official AnnouncementbyRSV Support Team·Jul 9, 2020Review of the basic concept of the RSV Solution and the token generation of RSV coinsAbout 13 basic concepts and Token generation
InRSV Official AnnouncementbyRSV Support Team·Jun 30, 2020On additional features and changes in RSV SolutionAbout 3 Specification changes
InRSV Official AnnouncementbyRSV Support Team·May 24, 2020Profit-sharing model when there is a change in allocation period06. The return of profits on RSV Solution
InRSV Official AnnouncementbyRSV Support Team·May 3, 2020Profit-sharing model by re-appropriation05. The return of profits on RSV Solution
InRSV Official AnnouncementbyRSV Support Team·Feb 16, 2020Profit-sharing model of only one beneficiary03. The return of profits on RSV Solution
InRSV Official AnnouncementbyRSV Support Team·Jan 27, 2020On profit variation due to an increase or a decrease of coin allocation02. The return of profits on RSV Solutions
